Trial intelligence / Profile preview

Yobee for dry scalp conditions

NCT03830177Phase 2Completed

Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Start
Jul 2019
Primary completion
Jan 2023
Modality
Microbiome Therapeutics
Countries
1
01

Overview

A Phase 2 trial of Yobee in seborrheic dermatitis (SD), atopic dermatitis (AD), pityriasis capitis, xerosis cutis, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Started Jul 2019; status: completed.

02

Drugs

Yobee
03

Conditions

seborrheic dermatitis (SD)atopic dermatitis (AD)pityriasis capitisxerosis cutis

Beyond the preview

Go deeper on NCT03830177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03830177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call